Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to -$10000.0.

  • IceCure Medical's Change in Account Payables fell 10180.51% to -$10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$98000.0, marking a year-over-year decrease of 18166.67%. This contributed to the annual value of $730000.0 for FY2024, which is 44433.96% up from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's Change in Account Payables is -$10000.0, which was down 10180.51% from $208000.0 recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Change in Account Payables registered a high of $554000.0 during Q3 2024, and its lowest value of -$627000.0 during Q4 2023.
  • Moreover, its 5-year median value for Change in Account Payables was $35000.0 (2021), whereas its average is $26631.6.
  • As far as peak fluctuations go, IceCure Medical's Change in Account Payables plummeted by 115500.0% in 2022, and later surged by 63793.1% in 2024.
  • IceCure Medical's Change in Account Payables (Quarter) stood at $42000.0 in 2021, then skyrocketed by 166.67% to $112000.0 in 2022, then crashed by 659.82% to -$627000.0 in 2023, then surged by 97.29% to -$17000.0 in 2024, then soared by 41.18% to -$10000.0 in 2025.
  • Its Change in Account Payables was -$10000.0 in Q3 2025, compared to $208000.0 in Q2 2025 and -$279000.0 in Q1 2025.